Windlas Biotech appoints Ms. Komal Gupta as CEO

Windlas Biotech Limited (Windlas), one of the top five players in the domestic pharmaceutical formulations contract development and manufacturing organization ("CDMO") industry in India, announced the appointment of Ms. Komal Gupta as CEO of the company. The Company is in the process of appointing the new Chief Financial Officer shortly and in the interim, Ms. Komal Gupta will continue as Chief Financial Officer.

Ms. Komal Gupta acted as the CFO of Windlas Biotech Limited and has an extensive experience in the field of Finance, Accounts, Taxation, Business Finance, Treasury and Compliance. Prior to joining the Company, she has worked with Anand Automotives Group (Perfect Circle India Limited, Mahle Filters Limited, Corporate office Anand Automotive Systems Limited) and DSM Group (DSM Sinochem Pharmaceuticals India Pvt. Ltd., now Centrient Pharmaceuticals India Pvt. Ltd.).

Mr. Hitesh Windlass and Mr. Manoj Kumar Windlass will continue as Managing Director and Joint Managing Director, respectively.

Commenting on the appointment, Mr. Hitesh Windlass, Managing Director, said, "We are delighted to appoint Komal to the position of CEO of Windlas Biotech. As we continue to accelerate our expansion strategy, her extensive industry experience and expertise in establishing longlasting alliances will be invaluable. Her remarkable skills and other operational disciplines have consistently contributed to the organization's fiscal prudence. We believe she will be the ideal leader to take on this role due to her extensive knowledge of our business and proven ability to achieve results consistently."

On the appointment as CEO, Ms. Komal Gupta said, "I am glad to move in more operational role as a CEO of the company. I am privileged to be given the opportunity to scale to the next level and remain committed to further strengthening the business excellency and DNA of Windlas. My experience of more than 7 years with the Company has allowed me to gain valuable insight in the day-to-day functioning which will enable me to further bring in operating efficiency. I look forward to working closely with Hitesh and Manoj on the Company's next phase of growth."

Shares of Windlas Biotech Ltd was last trading in BSE at Rs. 241.05 as compared to the previous close of Rs. 242.15. The total number of shares traded during the day was 1392 in over 196 trades.

The stock hit an intraday high of Rs. 243.75 and intraday low of 240.00. The net turnover during the day was Rs. 335497.00.

Source : Equity Bulls

Keywords

WindlasBiotech Appointment CEO